July 12, 2002 GNI co-founder to be featured in Japan's top biotech trade journal

Dr. Satoru Kuhara, GNI co-founder and member of the Kyushu Bioindustry Association executive committee, will be featured in a major article on genomic drug discovery methodologies in the August edition of Nikkei Bio Business. Dr. Kuhara's laboratory has pioneered the use of gene networks in drug discovery and has been a leader in the genome sequencing of important organisms involved in human disease. Nikkei haschosen to feature GNI as an important emerging company to follow in the sector in Japan and sites GNI as the leading example of an emerging trend in the technology commercialization process that combines best of breed Japanese technologies from national universities with global corporate structures and management teams.